Skip to main content

Table 2 Attacks treated with plasma-derived C1-inhibitor concentrate

From: Angioedema due to acquired C1-inhibitor deficiency: spectrum and treatment with C1-inhibitor concentrate

  pdC1-INH concentrate treated attacks
(N = 32)
Total Mean (SD)
Attacks treated with pdC1-INH concentrate, n 3636 113.6 (336.2)
Attacks treated by location, n
 Abdominal attacks 2522 78.8 (275.9)
 Facial attacks 954 29.8 (115.5)
 Extremity attacks 650 20.3 (65.8)
 Genital attacks 255 8.0 (43.5)
 Tongue attacks 71 2.2 (9.5)
 Laryngeal attacks 41 1.3 (3.4)
Attacks treated by dose, n
 500 U 2203 68.8 (300.7)
 1000 U 1095 34.2 (144.9)
 1500 U 22 0.7 (2.2)
 2000 U 315 9.8 (53.5)
 3000 U 1 0 (0.2)
  1. pdC1-INH = Plasma-derived C1-inhibitor; SD = Standard deviation